Inicio Blog Página 75

Esta es la razón por la que Apple deberá pagar 13,000 millones de impuestos a Irlanda

Por
-
0

Tras ocho años de batalla legal, el Tribunal de Justicia de la UE ha fallado a favor de la Comisión Europea. La decisión gira en torno al antiguo régimen fiscal “Double Irish», que permitía a multinacionales reducir sus obligaciones tributarias.

​Tras ocho años de batalla legal, el Tribunal de Justicia de la UE ha fallado a favor de la Comisión Europea. La decisión gira en torno al antiguo régimen fiscal “Double Irish», que permitía a multinacionales reducir sus obligaciones tributarias.   Noticias sobre negocios

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Por
-
0

Obesity often develops in childhood. In children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions induced a greater mean change in BMI than lifestyle interventions alone….

​   The New England Journal of Medicine: Search Results in Pediatrics

Childhood Obesity and GLP-1 Receptor Agonists — A Coming of Age?

Por
-
0

Childhood obesity, defined as an age-adjusted and sex-adjusted body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) in the 95th percentile or higher, according to the Centers for Disease Control and Prevention clinical growth charts (https://www.cdc.gov/obesity/index.html ), has been continually increasing in…

​   The New England Journal of Medicine: Search Results in Pediatrics

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Por
-
0

Obesity often develops in childhood. In children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions induced a greater mean change in BMI than lifestyle interventions alone….

​   The New England Journal of Medicine: Search Results in Gastroenterology

Childhood Obesity and GLP-1 Receptor Agonists — A Coming of Age?

Por
-
0

Childhood obesity, defined as an age-adjusted and sex-adjusted body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) in the 95th percentile or higher, according to the Centers for Disease Control and Prevention clinical growth charts (https://www.cdc.gov/obesity/index.html ), has been continually increasing in…

​   The New England Journal of Medicine: Search Results in Endocrinology

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Por
-
0

Obesity often develops in childhood. In children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions induced a greater mean change in BMI than lifestyle interventions alone….

​   The New England Journal of Medicine: Search Results in Endocrinology

Google pierde caso antimonopolio en la Unión Europea y enfrenta una multa millonaria

Por
-
0

La Unión Europea ha impuesto penalizaciones a Google por un valor conjunto superior a 9,000 millones de dólares en la última década.

​La Unión Europea ha impuesto penalizaciones a Google por un valor conjunto superior a 9,000 millones de dólares en la última década.   Noticias sobre negocios

El 57% de los contenidos de internet son generados o traducidos por IA

Por
-
0

Según un estudio reciente, el exceso de inteligencia artificial en la web corre el riesgo de colapsar los modelos.

​Según un estudio reciente, el exceso de inteligencia artificial en la web corre el riesgo de colapsar los modelos.   Noticias sobre negocios

A New Once-Weekly Insulin — Its Effectiveness and Safety

Por
-
0

Type 2 diabetes is a common yet complex disorder in which the key hormone for nutrient storage, insulin, is both ineffective and insufficient in most affected patients, resulting in high circulating levels of glucose. Most persons with type 2 diabetes have lost 80% of their ability to secrete insulin by…

​   The New England Journal of Medicine: Search Results in Endocrinology

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment

Por
-
0

In a phase 3 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily degludec. Efsitora was noninferior to degludec in reducing glycated hemoglobin levels.

​   The New England Journal of Medicine: Search Results in Gastroenterology

1...747576...841Página 75 de 841